Corti M C, Guralnik J M, Salive M E, Ferrucci L, Pahor M, Wallace R B, Hennekens C H
Epidemiology, Demography, and Biometry Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892-9205, USA.
Am J Cardiol. 1997 Jan 15;79(2):120-7. doi: 10.1016/s0002-9149(96)00697-2.
The association between iron levels and coronary artery disease (CAD) mortality is controversial. Whereas most data show no association, some have raised the possibility of a causal role, while others have suggested a protective effect of iron on CAD. To address these possibilities, we examined the association between serum iron and CAD, cardiovascular disease, and all-cause mortality in a large cohort of 3,936 persons aged > or =71 years who completed an interview, had a serum iron determination, and survived at least 1 year after baseline. The median follow-up time was 4.4 years. Serum iron levels were categorized according to sex-specific quartiles. Relative risks (RR) and 95% confidence intervals (CI) were calculated from proportional-hazards regression models adjusted for age, race, education, creatinine, serum albumin, serum lipids, use of iron supplementation, smoking, use of alcohol, blood pressure, body mass index, and presence of chronic conditions. There was a gradual decrease in the RRs of CAD, cardiovascular disease, and all-cause mortality with increasing serum iron levels (all tests for trend, p <0.05). Men in the highest iron quartile were one fifth as likely to die of CAD as men in the lowest iron quartile (RR 0.22; 95% CI 0.11 to 0.48), and women in the highest quartile had half the risk of women in the lowest quartile (RR 0.48; 95% CI 0.27 to 0.87). When compared with the lowest quartile, risk of all-cause mortality was 38% lower in men in the highest iron quartile (RR 0.62; 95% CI 0.46 to 0.85) and 28% lower in women in the highest quartile (RR 0.72; 95% CI 0.53 to 0.96). Results of similar strength and magnitude were observed for cardiovascular disease mortality and in analyses that excluded the first 3 years of follow-up. In this large cohort of persons aged > or =71 years, there was consistent evidence of increasing risk of mortality at lower serum iron levels. In fact, lower serum iron levels were associated with an increased risk of CAD, cardiovascular disease, and all-cause mortality. The results are compatible with the possibility that in an older population, there is an inverse association between serum iron levels and risk of mortality.
铁水平与冠状动脉疾病(CAD)死亡率之间的关联存在争议。尽管大多数数据显示两者无关联,但一些研究提出了因果关系的可能性,而另一些研究则表明铁对CAD有保护作用。为了探究这些可能性,我们在一个由3936名年龄≥71岁的人群组成的大型队列中,研究了血清铁与CAD、心血管疾病及全因死亡率之间的关联。这些人完成了访谈、进行了血清铁测定,并且在基线后存活至少1年。中位随访时间为4.4年。血清铁水平根据性别特异性四分位数进行分类。相对风险(RR)和95%置信区间(CI)通过对年龄、种族、教育程度、肌酐、血清白蛋白、血脂、铁补充剂使用情况、吸烟、饮酒、血压、体重指数和慢性病存在情况进行调整的比例风险回归模型计算得出。随着血清铁水平升高,CAD、心血管疾病和全因死亡率的RR逐渐降低(所有趋势检验,p<0.05)。血清铁水平处于最高四分位数的男性死于CAD的可能性仅为最低四分位数男性的五分之一(RR 0.22;95% CI 0.11至0.48),最高四分位数的女性风险是最低四分位数女性的一半(RR 0.48;95% CI 0.27至0.87)。与最低四分位数相比,血清铁水平处于最高四分位数的男性全因死亡率风险降低38%(RR 0.62;95% CI 0.46至0.85),最高四分位数的女性降低28%(RR 0.72;95% CI 0.53至0.96)。在心血管疾病死亡率以及排除随访前3年的分析中,观察到了强度和幅度相似的结果。在这个年龄≥71岁的大型队列中,有一致的证据表明血清铁水平较低时死亡风险增加。事实上,较低的血清铁水平与CAD、心血管疾病和全因死亡率风险增加相关。这些结果与老年人群中血清铁水平与死亡风险呈负相关的可能性相符。